Oncolytics Biotech Inc. (NASDAQ:ONCY) Q3 2023 Earnings Call Transcript
Operator: Good morning, and welcome to Oncolytics Biotech's Third Quarter 2023 Conference Call. All participants are now in listen-only mode.
Source: insidermonkey.com
Page 3 - Jon Patton News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Jon Patton. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Jon Patton Today - Breaking & Trending Today
Oncolytics Biotech® Reports Third Quarter 2023 Financial Results and Operational Highlights
Phase 1/2 survival data from GOBLET pancreatic cancer cohort demonstrates improvements over historical control trials Award and grant funding from Pancreatic Cancer Action Network provides...
Source: marketscreener.com
Oncolytics Biotech® and SOLTI Present Further Positive Pelareorep Translational Data at SITC
Novel imaging mass cytometry technology enables a closer look at tumor microenvironment post-pelareorep/atezolizumab/letrozole treatmentAffirms pelareorep's ability to increase PD-L1 positive cells...
Source: marketscreener.com
Oncolytics Presents Positive Updated Pancreatic Cancer Data from GOBLET Phase 1/2 Study at ESMO
7.2 months mPFS and 10.6 months interim median OS surpass historical outcomes by ≥ 25% T-cell expansion data correlate with tumor response, providing important proof-of-concept SAN DIEGO and...
Source: marketscreener.com
Oncolytics Biotech® to Host Conference Call to Discuss Third Quarter Financial Results and Recent Operational Highlights
/PRNewswire/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a clinical-stage immunotherapeutics company focused on oncology, today announced that it...
Source: prnewswire.com